Mesoblast Newsroom

Jefferies Downgrades Mesoblast to Hold From Buy; Price Target Is AU$2.30

MT NewswiresDec 23 04:06 ET

Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsDec 21 08:33 ET

Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $15

Moomoo NewsDec 20 13:33 ET

Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $30

Moomoo NewsDec 20 13:31 ET

Mesoblast Is Maintained at Overweight by Piper Sandler

Dow JonesDec 19 12:53 ET

Mesoblast Analyst Ratings

BenzingaDec 19 12:43 ET

Piper Sandler Maintains Overweight on Mesoblast, Raises Price Target to $15

BenzingaDec 19 12:43 ET

Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $18

Moomoo NewsNov 6 08:39 ET

Buy Rating for Mesoblast Driven by Promising Market Opportunities and Upcoming PDUFA Date for Ryoncil

TipRanksNov 6 07:47 ET

Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $11

Moomoo NewsOct 31 07:31 ET

Maxim Group Upgrades Mesoblast(MESO.US) to Buy Rating, Cuts Target Price to $12

Moomoo NewsSep 24 08:32 ET

Bell Potter Sticks to Their Buy Rating for Mesoblast Limited (MEOBF)

TipRanksAug 29 22:10 ET

Mesoblast Analyst Ratings

BenzingaAug 29 11:18 ET

Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Announces Target Price $11

Moomoo NewsAug 29 07:32 ET

Mesoblast (MESO) Receives a Buy From Piper Sandler

TipRanksAug 29 06:52 ET

Mesoblast Price Target Raised to $11.00/Share From $4.00 by Piper Sandler

Dow JonesJul 23 14:07 ET

Mesoblast Analyst Ratings

BenzingaJul 23 13:57 ET

Piper Sandler Upgrades Mesoblast(MESO.US) to Buy Rating

Moomoo NewsJul 23 13:32 ET

Mesoblast Limited (MEOBF) Was Downgraded to a Hold Rating at Jefferies

TipRanksJul 18 08:23 ET

Mesoblast Analyst Ratings

BenzingaJun 20 13:42 ET